The latest quarterly R&D expense is $135.90 Million with a QoQ Growth of +8.17%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $135.90M.
$135.90M
$135.90 Million
Q2 FY2026 · 2026-06-30
+8.17%
vs. $125.63M prior quarter
18
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $135.90M | +8.17% | +103.67% |
| Q1 FY2026Period end 2026-03-31 | $125.63M | +33.95% | +94.62% |
| Q4 FY2025Period end 2025-12-31 | $93.79M | +18.83% | +65.93% |
| Q3 FY2025Period end 2025-09-30 | $78.93M | +18.29% | +55.80% |
| Q2 FY2025Period end 2025-06-30 | $66.72M | +3.36% | +66.44% |
| Q1 FY2025Period end 2025-03-31 | $64.55M | +14.21% | +20.53% |
| Q4 FY2024Period end 2024-12-31 | $56.52M | +11.58% | +187.60% |
| Q3 FY2024Period end 2024-09-30 | $50.66M | +26.37% | +145.61% |
| Q2 FY2024Period end 2024-06-30 | $40.09M | -25.15% | +124.46% |
| Q1 FY2024Period end 2024-03-31 | $53.56M | +172.50% | +250.81% |
| Q4 FY2023Period end 2023-12-31 | $19.65M | -4.71% | -29.21% |
| Q3 FY2023Period end 2023-09-30 | $20.63M | +15.49% | +44.85% |
| Q2 FY2023Period end 2023-06-30 | $17.86M | +16.98% | -20.38% |
| Q1 FY2023Period end 2023-03-31 | $15.27M | -45.01% | +64.60% |
| Q4 FY2022Period end 2022-12-31 | $27.77M | +94.98% | N/A |
| Q3 FY2022Period end 2022-09-30 | $14.24M | -36.52% | N/A |
| Q2 FY2022Period end 2022-06-30 | $22.43M | +141.84% | N/A |
| Q1 FY2022Period end 2022-03-31 | $9.28M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
